Previous 10 | Next 10 |
You can read full article here. For further details see: Wall Street Breakfast: The Week Ahead (Podcast)
knowlesgallery/iStock via Getty Images The Alzheimer's Association International Conference begins Monday and runs through July 30 both in person in Denver and online. As always, there are several eagerly awaited presentations from companies working on Alzheimer's therapies that could lead to...
Oral Presentation to Highlight Data from the Ongoing Phase 2 Study of AL001 in FTD-GRN Company to Host Analyst and Investor Conference Call on July 29 at 1:00 p.m. ET SOUTH SAN FRANCISCO, Calif., July 21, 2021 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage ...
naphtalina/iStock via Getty Images COVID-19-related headlines dominated the holiday-shortened week as the Delta variant of the virus renewed pandemic fears across the globe. Meanwhile, with a ~1.3% gain over the past five-day period, the S&P 500 Healthcare Index outper...
4 Top Health Care Stocks To Watch In The Stock Market Today Whether we acknowledge it or not, health care stocks are part of one of the most significant sectors in the stock market today . The companies in the industry range from those that sell medical supplies, offer medical s...
naphtalina/iStock via Getty Images Jaguar Health rises on Street high target from Cantor Jaguar Health (JAGX) has risen ~15.4% in early trading after Cantor Fitzgerald began the coverage with an overweight rating. The Street-high target of $5.00 per share implies a premium of ~235.6...
Biopharmaceutical player, Alector Inc. ( NASDAQ: ALEC ), has skyrocketed in value this week by 90%, leading an increased number of investors to investigate the stock in more detail. In light of this increased demand, we thought it would be helpful to release an article explainin...
Several days after enjoying a massive 53% pop on news of an important new collaboration, Alector 's (NASDAQ: ALEC) stock got a fresh, 12% lift Tuesday from an analyst's dramatic price target increase. Citigroup prognosticator Neena Bitritto-Garg has caught a case of bull fever w...
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Alector, Inc. Shares Climb Following Immuno-Neurology Development Collaboration With GSK” Alector, Inc (NASDAQ: ALEC) surged over 39% in premarket trading after th...
Alector (NASDAQ: ALEC) was one of the most electrifying stocks on the market Friday, experiencing a monster 53% pop in midafternoon trading. This was entirely justified, given the company's announcement of an exciting new collaboration deal. Friday morning, Alector and pharmac...
News, Short Squeeze, Breakout and More Instantly...
--INVOKE-2 is the first global Phas e 2 trial evaluating the safety and efficacy of a TREM2 agonist, AL002, in slowing disease progression in individuals with early Alzheimer’s disease (AD)-- --Baseline characteristics data for the INVOKE-2 study confirm a representative stud...
SOUTH SAN FRANCISCO, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced presentations related to the Company’s TREM2 and progranulin programs at the upcoming Alzheimer's Associatio...
SOUTH SAN FRANCISCO, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in a corporate presentation at the H.C. Wainwright 5 th Annual Neuro Pers...